JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content.
Chapters
Summary
The genetically tractable nematode Caenorhabditis elegans can be used as a simple and inexpensive model for drug discovery. Described here is a protocol to identify anticancer therapeutics that inhibit the downstream signaling of RAS and EGFR proteins.